The immunhistochemical examination of GABAergic interneuron markers in the dorsolateral prefrontal cortex of patients with late-life depression

International Psychogeriatrics

Volumn 23, Issue 4, 2011, Pages 644-653

  Khundakar, Ahmad ^a   Morris, Christopher ^a   Thomas, Alan J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

depression; dorsolateral prefrontal cortex; elderly; GABA; immunohistochemistry

Indexed keywords

ANTIBODY; CALBINDIN; CALRETININ; PARVALBUMIN; 4 AMINOBUTYRIC ACID; BIOLOGICAL MARKER;

AGED; ARTICLE; AUTOPSY; CELL SUBPOPULATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GABAERGIC TRANSMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNEURON; LATE LIFE DEPRESSION; MALE; NEUROBIOLOGY; PH; PREFRONTAL CORTEX; PROTEIN BINDING; AGING; CADAVER; CASE CONTROL STUDY; DEPRESSION; METABOLISM;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; PARVALBUMINS; POSTMORTEM CHANGES; PREFRONTAL CORTEX;

EID: 80051725485     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610210001444     Document Type: Article

References (28)

1. Akil, M. and Lewis, D. A. (1992). Differential distribution of parvalbumin-immunoreactive pericellular clusters of terminal boutons in developing and adult monkey neocortex. Experimental Neurology, 115, 239-249.
2. Alexopoulos, G. S., Meyers, B. S., Young, R. C., Kakuma, T., Silbersweig, D. and Charlson, M. (1997). Clinically defined vascular depression. American Journal of Psychiatry, 154, 562-565.
3. Baldwin, R. C. (2005). Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. International Journal of Geriatric Psychiatry, 20, 1-11.
4. Beasley, C. L., Zhang, Z. J., Patten, I. and Reynolds, G. P. (2002). Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biological Psychiatry, 52, 708-715.
5. Brambilla, P., Perez, J., Barale, F., Schettini, G. and Soares, J. C. (2003). GABAergic dysfunction in mood disorders. Molecular Psychiatry, 8, 721-737.
6. Cotter, D. et al. (2002a). The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biological Psychiatry, 51, 377-386.
7. Cotter, D., Mackay, D., Chana, G., Beasley, C., Landau, S. and Everall, I. P. (2002b). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex, 12, 386-394.
8. Gabbott, P. L., Jays, P. R. and Bacon, S. J. (1997). Calretinin neurons in human medial prefrontal cortex (areas 24a, b, c, 32, and 25). Journal of Comparative Neurology, 381, 389-410.
9. Gonzalez-Burgos, G., Krimer, L. S., Povysheva, N. V., Barrionuevo, G. and Lewis, D. A. (2005). Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. Journal of Neurophysiology, 93, 942-953.
10. Gundersen, H. J. et al. (1988). The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 96, 857-881.
11. Herrmann, L. L., Le Masurier, M. and Ebmeier, K. P. (2008). White matter hyperintensities in late life depression: a systematic review. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 619-624.
12. Jacobowitz, D. M. and Winsky, L. (1991). Immunocytochemical localization of calretinin in the forebrain of the rat. Journal of Comparative Neurology, 304, 198-218.
13. Khundakar, A. A. and Zetterstr̈om, T. S. (2006). Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain Research, 1106, 12-20.
14. Khundakar, A. A., Morris, C. M., Oakley, A. E., McMeekin, W. and Thomas, A. J. (2009). Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression. British Journal of Psychiatry, 195, 163-169.
15. Khundakar, A., Morris, C., Oakley, A. and Thomas, A. J. (2010). Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in late-life depression. American Journal of Psychiatry, in press.
16. Lewis, D. A. and Lund, J. S. (1990). Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor-and parvalbumin- immunoreactive populations. Journal of Comparative Neurology, 293, 599-615.
17. Lewis, D. A. and Moghaddam, B. (2006). Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Archives of Neurology, 63, 1372-1376.
18. Lewis, D. A., Cruz, D. A., Melchitzky, D. S. and Pierri, J. N. (2001). Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. American Journal of Psychiatry, 158, 1411-1422.
19. Ongur, D., Drevets, W. C. and Price, J. L. (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America, 95, 13290-13295.
20. Perry, E. H. (1993). Coronal Maps of Brodmann Areas in the Human Brain. London: Wolfe.
21. Rajkowska, G. et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry, 45, 1085-1098.
22. Rajkowska, G., Miguel-Hidalgo, J. J., Dubey, P., Stockmeier, C. A. and Krishnan, K. R. (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biological Psychiatry, 58, 297-306.
23. Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A. and Miguel-Hidalgo, J. J. (2007). GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology, 32, 471-482.
24. Thomas, A. J. et al. (2000). Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. American Journal of Psychiatry, 157, 1682-1684.
25. Thomas, A. J., Ferrier, I. N., Kalaria, R. N., Perry, R. H., Brown, A. and O'Brien, J. T. (2001). A neuropathological study of vascular factors in late-life depression. Journal of Neurology, Neurosurgery, and Psychiatry, 70, 83-87.
26. Thomas, A. J., Ferrier, I. N., Kalaria, R. N., Davis, S. and O'Brien, J. T. (2002a). Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. British Journal of Psychiatry, 181, 129-134.
27. Thomas, A. J. et al. (2002b). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Archives of General Psychiatry, 59, 785-792.
28. Zarate, C. A., Jr. et al. (2003). Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Annals of the New York Academy of Sciences, 1003, 273-291.